MA27024A1 - Derives d'imidazo [1,5-a] pyrimido [5,4-d] benzazepine en tant que modulateurs du recepteur gaba a - Google Patents

Derives d'imidazo [1,5-a] pyrimido [5,4-d] benzazepine en tant que modulateurs du recepteur gaba a

Info

Publication number
MA27024A1
MA27024A1 MA27398A MA27398A MA27024A1 MA 27024 A1 MA27024 A1 MA 27024A1 MA 27398 A MA27398 A MA 27398A MA 27398 A MA27398 A MA 27398A MA 27024 A1 MA27024 A1 MA 27024A1
Authority
MA
Morocco
Prior art keywords
pyrimido
gaba
imidazo
receptor modulators
benzazepine derivatives
Prior art date
Application number
MA27398A
Other languages
English (en)
Inventor
Raffaello Masciadri
Andrew William Thomas
Juergen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA27024A1 publication Critical patent/MA27024A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MA27398A 2001-05-18 2003-11-14 Derives d'imidazo [1,5-a] pyrimido [5,4-d] benzazepine en tant que modulateurs du recepteur gaba a MA27024A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01112222 2001-05-18

Publications (1)

Publication Number Publication Date
MA27024A1 true MA27024A1 (fr) 2004-12-20

Family

ID=8177471

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27398A MA27024A1 (fr) 2001-05-18 2003-11-14 Derives d'imidazo [1,5-a] pyrimido [5,4-d] benzazepine en tant que modulateurs du recepteur gaba a

Country Status (37)

Country Link
US (1) US6686352B2 (fr)
EP (1) EP1399448B1 (fr)
JP (1) JP4068466B2 (fr)
KR (1) KR100533406B1 (fr)
CN (1) CN1230436C (fr)
AR (1) AR033753A1 (fr)
AT (1) ATE283857T1 (fr)
AU (1) AU2002338898B2 (fr)
BG (1) BG108369A (fr)
BR (1) BR0209859A (fr)
CA (1) CA2446903C (fr)
CZ (1) CZ20033355A3 (fr)
DE (1) DE60202147T2 (fr)
DK (1) DK1399448T3 (fr)
EC (1) ECSP034851A (fr)
ES (1) ES2232778T3 (fr)
GT (1) GT200200087A (fr)
HR (1) HRP20030890A2 (fr)
HU (1) HUP0400743A3 (fr)
IL (2) IL158572A0 (fr)
JO (1) JO2297B1 (fr)
MA (1) MA27024A1 (fr)
MX (1) MXPA03010529A (fr)
MY (1) MY127570A (fr)
NO (1) NO20035104L (fr)
NZ (1) NZ529097A (fr)
PA (1) PA8545201A1 (fr)
PE (1) PE20030041A1 (fr)
PL (1) PL366846A1 (fr)
PT (1) PT1399448E (fr)
RU (1) RU2287531C2 (fr)
SI (1) SI1399448T1 (fr)
SK (1) SK15252003A3 (fr)
TW (1) TWI251489B (fr)
WO (1) WO2002094834A1 (fr)
YU (1) YU90003A (fr)
ZA (1) ZA200308544B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101792651B1 (ko) 2004-05-14 2017-11-20 밀레니엄 파머슈티컬스 인코퍼레이티드 아우로라 키나아제의 억제에 의해 유사분열 진행을 억제하기 위한 화합물 및 그 화합물을 포함하는 약학적 조성물
EP1799684B1 (fr) * 2004-10-04 2014-12-03 Millennium Pharmaceuticals, Inc. Composés à base de lactame utiles en tant qu'inhibiteurs de la protéine kinase
RU2007114763A (ru) * 2004-10-20 2008-11-27 Ф.Хоффманн-Ля Рош Аг (Ch) Галогенозамещенные производные бензодиазепинов
NZ554439A (en) * 2004-10-20 2009-09-25 Hoffmann La Roche Imidazo-benzodiazepine derivatives
JP4885967B2 (ja) 2005-10-11 2012-02-29 エフ．ホフマン−ラ ロシュ アーゲー イミダゾベンゾジアゼピン誘導体
PE20080145A1 (es) 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
JP5562865B2 (ja) 2007-12-17 2014-07-30 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｔｒｐｖ１のイミダゾロ−、オキサゾロ−、及びチアゾロピリミジン・モジュレーター
CN101735211B (zh) * 2008-11-04 2012-11-14 复旦大学 2,3-二氢[1,5]苯并噻氮杂*类化合物或其盐在制备GSK-3β抑制剂中的用途
US7998952B2 (en) 2008-12-05 2011-08-16 Millennium Pharmaceuticals, Inc. Thiolactams and uses thereof
CN102264368B (zh) 2008-12-22 2014-09-10 米伦纽姆医药公司 极光激酶抑制剂与抗cd20抗体的组合
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
WO2011103089A1 (fr) 2010-02-19 2011-08-25 Millennium Pharmaceuticals, Inc. Formes cristallines de 4-{[9-chloro-7-(2-fluoro-6--méthoxyphényl)-5h-pyrimido[5,4-d][2]benzazépin-2yl]amino}-2-méthoxybenzoate de sodium
CN101891706B (zh) * 2010-04-09 2013-05-29 复旦大学 3,4-二氢苯并[f][1,4]噻氮杂*类化合物或其盐及其药物用途
CN102424670A (zh) * 2011-10-31 2012-04-25 江苏阿尔法药业有限公司 一种合成3-(3-氯丙基)-1,3,4,5-四氢-7,8-二甲氧基-2h-3-苯并氮杂卓-2-酮的方法
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
EP2976086B1 (fr) 2013-03-22 2020-10-14 Millennium Pharmaceuticals, Inc. Combinaison d'inhibiteurs catalytiques de mtorc1/2 et inhibiteurs sélectifs de la kinase aurora a
EP4032889B1 (fr) * 2013-12-20 2026-05-06 Agenebio, Inc. Dérivés de benzodiazépine, compositions et méthodes de traitement de déficience cognitive
EP3310785B1 (fr) 2015-06-19 2024-11-20 Agenebio, Inc. Dérivés de benzodiazépine, compositions et méthodes de traitement de la déficience cognitive
EP3324976A4 (fr) 2015-07-21 2019-03-27 Millennium Pharmaceuticals, Inc. Administration d'inhibiteur de kinase aurora et d'agents chimiothérapeutiques
US20180170941A1 (en) 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AU2019288382B2 (en) 2018-06-19 2024-07-25 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CN110452172B (zh) * 2019-08-21 2021-03-26 爱斯特（成都）生物制药股份有限公司 一种苯并己内酰胺的合成方法
CN112159411A (zh) * 2020-10-15 2021-01-01 南京工业大学 一种三氟甲基取代嘧啶并[1,3]二氮杂*化合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2607503B1 (fr) * 1986-12-02 1989-02-24 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
TW201311B (fr) 1991-06-17 1993-03-01 Hoffmann La Roche
RU2119496C1 (ru) * 1992-04-14 1998-09-27 Научно-исследовательский институт фармакологии Российской академии медицинских наук Производные n-ацилпролилдипептидов
FR2728902B1 (fr) * 1994-12-29 1997-01-31 Synthelabo Derives d'acide 8-oxo-5,8-dihydro-6h-dibenzo(a,g)quinolizine-13-propanoique, leur preparation et leur application en therapeutique
AU2793199A (en) * 1998-02-26 1999-09-15 Neurogen Corporation 2-(het-)aryl-4-(cyclic amino substituted) heteroaryl fused pyridine derivatives,their preparation and their use as (ant-)agonists for gaba (a) brain receptors
US6177569B1 (en) * 1998-08-25 2001-01-23 Neurogen Corporation Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
FR2783828B1 (fr) 1998-09-29 2000-11-10 Synthelabo Derives d'acide 5,6-dihydro-4h-imidazo[1,2-a][1] benzazepine -1-acetique, leur preparation et leur application en therapeutique
AU1481701A (en) 1999-11-12 2001-06-06 Neurogen Corporation Bicyclic and tricyclic heteroaromatic compounds
TWI239333B (en) 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators

Also Published As

Publication number Publication date
GT200200087A (es) 2003-06-19
SI1399448T1 (en) 2005-02-28
RU2003136078A (ru) 2005-05-27
HUP0400743A3 (en) 2007-09-28
CZ20033355A3 (en) 2004-07-14
ECSP034851A (es) 2003-12-24
JP2004531563A (ja) 2004-10-14
CA2446903C (fr) 2008-12-30
EP1399448B1 (fr) 2004-12-01
HUP0400743A2 (hu) 2004-07-28
ATE283857T1 (de) 2004-12-15
ES2232778T3 (es) 2005-06-01
NO20035104D0 (no) 2003-11-17
ZA200308544B (en) 2005-01-31
KR20040002975A (ko) 2004-01-07
PA8545201A1 (es) 2003-02-28
PE20030041A1 (es) 2003-02-07
DE60202147T2 (de) 2005-12-01
SK15252003A3 (sk) 2004-08-03
MXPA03010529A (es) 2004-03-02
NZ529097A (en) 2005-04-29
CN1230436C (zh) 2005-12-07
CA2446903A1 (fr) 2002-11-28
BR0209859A (pt) 2004-06-15
DE60202147D1 (de) 2005-01-05
HRP20030890A2 (en) 2005-08-31
DK1399448T3 (da) 2005-04-11
AU2002338898B8 (en) 2002-12-03
JP4068466B2 (ja) 2008-03-26
NO20035104L (no) 2003-11-17
US6686352B2 (en) 2004-02-03
PT1399448E (pt) 2005-03-31
HK1066544A1 (en) 2005-03-24
KR100533406B1 (ko) 2005-12-02
YU90003A (sh) 2006-08-17
MY127570A (en) 2006-12-29
JO2297B1 (en) 2005-09-12
US20030055042A1 (en) 2003-03-20
IL158572A (en) 2010-02-17
AU2002338898B2 (en) 2007-03-15
RU2287531C2 (ru) 2006-11-20
WO2002094834A1 (fr) 2002-11-28
EP1399448A1 (fr) 2004-03-24
AR033753A1 (es) 2004-01-07
TWI251489B (en) 2006-03-21
IL158572A0 (en) 2004-05-12
BG108369A (bg) 2005-01-31
CN1509289A (zh) 2004-06-30
PL366846A1 (en) 2005-02-07

Similar Documents

Publication Publication Date Title
DK1399448T3 (da) Imidazo[1,5-a]pyrimido[5,4-d]benzazepin-derivater som GABA A-receptormodulatorer
DK1699795T3 (da) Substituerede 8'-pyri(mi)dinyldihydrospiro[cycloalkylamin]-pyrimido[1,2-a]pyrimidin-6-onderivater
DK1198464T3 (da) 8-phenyl-6,9-dihydro[1,2,4]triazolo[3,4-i]purin-5-onderivater
DK1686130T3 (da) Pyrrolo-[2,3-d]-pyrimidinforbindelser som immunsuppressive midler
MA26825A1 (fr) Derives de pyrazolo [4,3-d] pyrimidine
NO20041142L (no) Subsitituerte 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-on og 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)on-derivater for neurodegenerative lidelser
NO20054330D0 (no) 8-substituerte-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
NO20054331D0 (no) Substituerte-8-perfluoralkyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
PT1674456E (pt) Utilização de 2-fluoro-3-cetoésteres para preparar 3-fluoro- 6,7,8,9-tetra-hidro-4-h-pirimido[1,2-a]pirimidin-4-onas
DE60103909D1 (de) 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on- und 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5 1honderivate
NO20013384D0 (no) Imidazo[4,5-c]pyridin-4-on-derivater
EE200100377A (et) Imidaso[1,5-a]-pürido[3,2-e]-pürasinoonide kasutamine arstimitena
NO20013645L (no) Anvendelse av pyridazino[4,5-b]indol-1-acetamid-derivater for fremstilling av medisiner for behandling av sykdommer relatert tildysfunksjon av de perifere benzodiazepinreseptorer
HU0103075D0 (en) Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one derivatives and intermediates thereof
DK1678182T3 (da) Fremgangsmåde til fremstilling af substituerede 5-amino-pyrazolo[4,3-E]-1,2,4-triazolo-[1,5-C]pyrimidiner
PL370067A1 (en) 8-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid amide
HUP0401991A3 (en) Method for producing of substituted imidazo[1,2-a]-5,6,7,8-tetrahydropyridine-8-on derivatives
EE200100700A (et) Asendatud [1,4]diasepino[6,7,1-hi]indool-4-oonidevalmistamismeetod
DK1330457T3 (da) Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoler som 5HT2C-antagonister
AU2002228541A1 (en) Novel forms of 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo (1,2-a)pyridine-6-carboxamide
AU2002226861A1 (en) Novel forms of 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo (1,2-a)pyridine-6-carboxamide